| (210) | Number of the EPO application | 16857961 |
| (220) | Filing date of the EPO application | 2016.09.16 |
| (80) | EPO patent specification publication (B) | EPB nr. 30/2023, 2023.07.26 |
| (110) | EPO patent number | 3365336 |
| (21) | Number of the application | e 2018 0842 |
| (71) | Name(s) of applicant(s), code of the country | Neuform Pharmaceuticals, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | HUANG Chaoran, US;
CHENG Changfu, US; |
| (73) | Name(s) of owner(s), code of the country | NEUFORM Pharmaceuticals Inc., US; |
| (54) | Title of the invention | DEUTERATED COMPOUNDS FOR TREATING HEMATOLOGIC MALIGNANCIES, AND COMPOSITIONS AND METHODS THEREOF |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07D 401/14 (2006.01.01); C07D 403/14 (2006.01.01); C07B 59/00 (2006.01.01); A61P 35/00 (2006.01.01); A61K 31/53 (2006.01.01); A61K 31/444 (2006.01.01); A61P 35/02 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.10.31 |
| (30) | Priority | 201562244267 P, 2015.10.21, US |
| (86) | International application | PCT/US2016/052130, 2016.09.16 |
| (87) | International publication | WO 2017/069878, 2017.04.27 |